Moon Surgical gets FDA nod for AI-enhancement for surgical robot

Moon Surgical announced today that it received FDA clearance for ScoPilot, a Nvidia-enabled platform for its Maestro surgical robot.

The Paris-based company also announced further integrations with Nvidia technologies, including the Isaac for Healthcare platform.

The news was part of a host of medtech AI announcements this week as Nvidia holds its GTC 2025 event in San Jose, California. (We have a full roundup of medtech AI news out of Nvidia’s “Super Bowl of AI.”)

ScoPilot, enabled by Nvidia Holoscan, is a real-time sensing platform designed to develop and deploy applications based on AI in the OR. It runs locally on Moon Surgical’s Maestro system, making it the first AI application to run intraoperatively on any commercially available surgical robotic platform with Holoscan, according to a news release.

Sign up for Blog Updates